News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Commentary|Videos|July 12, 2023

Approach to Treatment in Patients with MDD

Author(s)Greg Mattingly, MD, Jeremy Schreiber, MSN, PMHNP-BC

Practitioners discuss their approach to treatment with their patients with major depressive disorder (MDD).

Episodes in this series

EP. 1 Healthcare Perception of Major Depressive Disorder

EP. 1 Healthcare Perception of Major Depressive Disorder

EP. 2 Undertreatment in Patients Suffering From MDD

EP. 2 Undertreatment in Patients Suffering From MDD

Experts on MDD.

EP. 3 Tailoring Treatments for Patients With MDD

Experts on MDD.

EP. 4 MDD as a Chronic Condition

EP. 5 Approach to Treatment in Patients with MDD

EP. 5 Approach to Treatment in Patients with MDD

EP. 6 MDD Treatment: Follow-Up

EP. 6 MDD Treatment: Follow-Up

EP. 7 MDD Remission

EP. 7 MDD Remission

EP. 8 Treatment Switch for MDD

EP. 8 Treatment Switch for MDD

EP. 9 New Classes of Treatment for MDD

EP. 9 New Classes of Treatment for MDD

EP. 10 Practice Pearls for Optimizing MDD Treatment

EP. 10 Practice Pearls for Optimizing MDD Treatment

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

Southern California Psychiatry Conference

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Trending on Psychiatric Times

Podcast: Practical Insights Into the Evolving Treatment of Bipolar Disorder With David Dunner, MD, FACPsych

New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD

Preventing Relapse in Schizophrenia: Focus on Women’s Mental Health

Metabolic Risk, Residual Insomnia, and Seltorexant

Seltorexant as Adjunctive Therapy for MDD With Insomnia